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The relation between oxidative stress and adhesion molecules in Egyptian 
children and adolescents with type 1 diabetes mellitus  
 
INTRODUCTION 
Type1 diabetic patients usually develop clinically 
evident microangiopathy later in adolescence 
although subclinical functional and structural 
abnormalities precede its development1. 
Microangiopathy in type1 diabetes mellitus 
(T1DM) is associated with platelet hyperactivity, 
endothelial dysfunction and low grade 
inflammation2. 
Endothelial dysfunction is known to be responsible 
for diabetic vascular complications3. Oxidative 
stress (OS) contributes significantly to this 
dysfunction by disturbing the balance between 
production of reactive oxygen species (ROS) and 
antioxidant defense in favor of the former, leading 
to tissue injury4. Malondialdehyde (MDA) is one of 
the end products of lipid hydroperoxide 
decomposition and it is the most important marker 
measured as an index of lipid peroxidation3. 
Original article 
Background: Antioxidant potential decreases while plasma lipid peroxidation 
products increase in type1 diabetes mellitus. The vascular endothelium is a 
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disease duration less than 5 years and 16 patients with duration of 5 years or 
more. Thirty healthy age and sex matched subjects served as controls. They 
were assessed clinically. Laboratory investigations included, random blood 
sugar (RBS), glycated hemoglobin (HbA1c), fasting lipid profile and 
measurement of serum malondialdehyde (MDA) as a marker of lipid 
peroxidation and serum soluble P-selectin as a marker of endothelial/platelet 
activation. Results: Serum MDA and P-selectin were significantly elevated in 
type 1 diabetics compared to controls with the highest level in diabetics with 
disease duration of 5 years or more (p < 0.0001). Both MDA and P-selectin 
levels were significantly elevated in complicated compared to non complicated 
diabetics (P<0.0001) with strong relation to complication severity. Serum MDA 
level was positively correlated with serum P-selectin level in diabetics (p 
<0.0001). Serum MDA and P-selectin were positively and significantly 
correlated with disease duration (p<0.0001 ), RBS (p<0.0001,p=0.001 
respectively), HbA1c (p<0.0001), diastolic blood pressure (p=0.03,p=0.005 
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(p=0.006, p<0.0001 respectively) and low density lipoproteins (p=0.03,p=0.05 
respectively) but negatively correlated with high density lipoproteins(p=0.03). 
On multiple regression analysis, HbA1c had the strongest effect on both MDA 
and P-selectin levels (P<0.0001). Cut off values for serum MDA and P-
selectin equal to 8.035 nmoles/ml and 45.15ng/dl respectively for early 
detection of diabetic MVCs were defined. Conclusion: Levels of MAD and 
P-selectin are elevated in type1 diabetics with evident relation to disease 
duration, metabolic control and severity of MVCs. Hence both of them might 
act as good markers to identify diabetics who are more susceptible to 
develop vascular disease.  
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The vascular endothelium is the primary target of 
OS. Upon exposure to ROS, endothelial cells 
display a variety of adverse biological effects 
including production of inflammatory mediators, 
expression of adhesion molecules and increased cell 
permeability5. Leucocyte adhesion and migration to 
the sub-endothelium in response to chemo-
attractants and other activating molecules are 
mediated by adhesion molecules expressed on 
endothelial cells including E-selectin, P-selectin, 
vascular cell adhesion molecule 1 (VCAM-1) and 
intercellular adhesion molecule-1 (ICAM-1)6. 
The main role of selectin group is the tethering of 
leucocytes to the endothelium; they induce 
relatively weak and transient adhesion allowing the 
cells to roll along the vascular wall7. Thus, they 
play a part in the earliest stages of endothelial 
dysfunction and microangiopathy. One of the most 
important members of this group is P-selectin8.  
P-selectin is found in the storage granules of resting 
platelets as well as in the weibel–palade bodies of 
endothelial cells. After endothelial or platelet 
activation, P-selectin may also be deposited on the 
provisional matrix providing a surface for 
recruitment and subsequent migration of leucocytes 
including monocytes, mediating the initial steps of 
inflammation9. Elevated level of p-selectin has been 
shown to predict future vascular risk10. 
The aim of this study was to investigate whether OS 
and adhesion molecules derived from 
endothelial/platelet activation were interrelated in 
T1DM in order to clarify the effect of OS on the 




This study included 38 children and adolescents 
with T1DM recruited from the regular attendants of 
the Diabetes Clinic, Children's Hospital, Ain Shams 
University. They were 11 (29.0%) males and 27 
(71.0%) females, their ages ranged between 6-17 
years with a mean of 11.30 ± 3.10 years. They were 
subdivided into two groups according to their 
disease duration. 
Group I:  included 22 patients with diabetes 
duration less than 5 years (range was 6 months to 4 
years) with a mean of 2.36±1.28 years. Their ages 
ranged between 6-17 years with a mean of 
10.98±3.41 years. They were 5 (22.7%) males and 
17 (77.3%) females. 
Group II:  included 16 patients with diabetes 
duration of 5 years or more (range was 5 to 10 
years) with a mean of 6.75±2.12 years. Their ages 
ranged between 8-14.5 years with a mean of 
12.19±1.89 years. They were 6 (37.5%) males and 
10 (62.5%) females. 
Control group: included 30 healthy ages and sex 
matched subjects. Their ages ranged between 6-17 
years with a mean of 10.33±4.15 years. They were 
14 (46.7%) males and 16 (53.3%) females. 
All patients and controls were subjected to the 
following: 
I. Clinical history taking stressing on; 
demographic data, disease duration and insulin 
therapy regarding its type, dose and frequency. 
The mean insulin dose was calculated. History 
suggestive of acute metabolic complications and 
numbers of hypoglycemic and diabetic 
ketoacidosis (DKA) attacks were recorded. The 
files were revised for the number of hospital 
admissions due to these attacks during the last 
one year prior to the study. Inquiry about chronic 
diabetic complications including nephropathy, 
peripheral neuropathy and retinopathy was made. 
II- Clinical examination: with particular emphasis 
on:  
1. Anthropometric measures; height, weight and 
body mass index standard deviation scores 
(SDS) were calculated11. 
2. Full neurological examination to detect 
evidence of peripheral neuropathy. 
3. Blood pressure measurement by conventional 
mercurial sphygmomanometer after 5 minutes 
rest, blood pressure was measured three times 
for every patient and the mean value of the 
three readings was calculated. 
4. Fundus examination, by direct ophthalmoscopy 
to detect diabetic retinopathy.  
III- Laboratory investigations: included 
1. Random blood sugar (RBS); using glucocard II 
blood glucose monitoring system supplied by 
ARKRAY, Inc. 
2. Glycosylated hemoglobin (HbAlc); using 
quantitative calorimetric determination of 
glyco-hemoglobin in whole blood.   
3. Quantitative determination of urinary 
microalbumin for diabetic nephropathy. 
Microalbuminuria was defined as albumin 
excretion rate of 30- 300 mg/gm urinary 
creatinine. 
 Calculation of mean random blood glucose 
(MRBG) and mean HbAlc in the last one year 
prior to the study through revision the patients' 
files were done. 
4. Fasting lipid profile assay using the enzymatic 
colorimetric method for measuring serum total 
cholesterol (TC), serum triglycerides (TG), low 
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density lipoproteins (LDL) and serum high 
density lipoproteins (HDL). 
5.  Assessment of lipid peroxidation by measuring 
serum malondialdehyde as a marker of OS, by 
colorimetric method (Biodiagnostic, Comp with 
catalog number MD 25- 28). In this method 
thiobarbituric acid (TBA) reacts with MDA in 
acidic medium at temperature of 95°C for 30 
min to form thiobarbituric acid reactive 
product. The absorbance of the resultant pink 
product was measured at 534 nm. 
6.  Measurement of serum soluble P-selectin (s P-
selectin) by quantitative sandwich enzyme-
linked immunosorbent assay (ELISA) (Bender 




All data were processed using SPSS (version 11). 
The mean and standard deviation were calculated, 
the level P ≤ 0.05 was considered the cut-off value 
for significance. Chi-Square test Χ ² was used to 
test the association variables for categorical 
(descriptive) data. Fisher exact test was performed 
in table containing value less than 5. Student's t-test 
was used to assess the statistical significance of the 
difference between means of independent samples. 
Values not normally distributed were tested using 
Mann-Whitney test. One way ANOVA test was 
used to compare more than 2 quantitative groups. 
Correlation analysis was employed to assess the 
strength of association between two variables.  
Sensitivity, specificity positive predictive value 
(PPV) and negative predictive value (NPP) were all 
calculated. A receiver operating characteristic 
(ROC) curve was used to illustrate the diagnostic 




The demographic, anthropometric measurements 
and mean values of blood pressure of all studied 
groups are presented in table (1). There were no 
significant differences among the three studied 
groups as regards their mean age, weight , height 
and BMI SDS (p>0.05). The three studied groups 
were comparable also with respect to their mean 
systolic blood pressure (p>0.05), although a 
significantly higher diastolic blood pressure was 
found in group II compared to other groups (p= 
0.04). 
Mean RBS and mean insulin dose, were higher 
in group II compared to group I although this did 
not reach statistical significance (p>0.05). On the 
other hand group II had significantly higher HbA1c 
compared to group I (p=0.03). 
Number of DKA attacks in group II was 
significantly higher compared to group I (p= 0.04). 
A higher median number of hypoglycemic attacks 
was seen in group I compared to group II; however 

















Test of significance p value




(6-17) F=0.74 0.48 
M/F 5/17 6/10 14/16 X2 = 2.38 0.30 




(-2.00-0.85) F= 1.37 0.26 




(-2.00-4.50) F=0.13 0.88 












(90-120) F=1.45 0.25 







(50-80) F=4.64 0.04 
Group I: Patients with disease duration less than five years.      F=ANOVA 
Group II: Patients with disease duration five or more years.       X2 = chi-square 
BMI=Body mass index.     SDS=Standard deviation score 
M/F=Male/female 
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Group II diabetics had significantly higher 
percentage of peripheral neuropathy (75%) and 
nephropathy (50%) compared to group I diabetics 
(9.1% and 0% respectively). Diabetic retinopathy 
occurred in 12.5% and 0% of group II and group I 
patients respectively (P = 0.27). 
 
As regards the lipid profile; serum TC, TG 
and LDL were  significantly higher in diabetics 
with disease duration of 5 years or more 
compared to other groups while HDL was 
significantly lower in group II compared to group 
I diabetics and controls  table (3), Fig. (1).  
Table 2. Metabolic control, acute and chronic diabetic complications in the studied patients. 
 
Variant Group I N=22 
Group II 
n=16 Test of significance  p value 
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Nephropathy n (%) 

















DKA: Diabetic ketoacidosis; MVCs: Microvascular complications, n: Number; HbA1c: glycosylated hemoglobin and 
*: Fisher Exact test, Z: MannWhitney, t: Student t test 
 
 
Table 3. Comparison between the three studied groups regarding their lipid profile, MDA and P-selectin 
levels. 
Group I Group II Control 
Variable 
n=22 n=16 n=30 Test of significance  P value 
Mean ±SD 175.05±29.1 199.38±37.15 159.53±9.01 
TC(mg/dl 
Range (110-240) (145-268) (148-180) 
F=6.11 0.005 
Mean ±SD 64.95±17.73 111.13±46.34 47.6±6.56 
TG (mg/dl) 
Range (42-127) (50-198) (40-60) 
F = 20.12 < 0.0001 
Mean ±SD 100.14±17.66 127.25±32.12 81.27±8.16 
LDL (mg/dl) 
Range (72-134) (89-191) (69-98) 
F = 15.88 < 0.0001 
Mean ±SD 51.77±11.90 41.38±3.2 57.80±6.53 
HDL (mg/dl) 
Range (27-83) (37-48) (48-67) 
F = 8.13 0.001 
Mean ±SD 9.67±1.24 13.56±3.05 5.36±1.63 
MDA (nmol/ml) 
Range (7.83-12.11) (9.64-17.9) (3.8-8.5) 
F=58.59 < 0.0001 
Mean ±SD 58.74±15.51 116.43±43.76 34.03±6.29 
P-selectin (ng/dl) 
Range (28.1-89.7) (61.7-189) (24.1-44.1) 
F=39.33 < 0.0001 
NS=Non-significant (p>0.05).  MDA= Malondialdehyde  
S=Significant (p≤0.05).   HDL = High density lipoprotein  
HS=highly significant (p≤0.01).  LDL = Low density lipoprotein  
TG = Triglycerides                                       T C= Total cholesterol 
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Figure 1. Mean values of lipid profile in the three studied groups. 
 
  
 Serum MDA and P-selectin were significantly 
higher in group II compared to group I diabetics 
and controls (p <0.0001) (Fig. 2a, b). Moreover, 
significantly higher mean MDA and P-selectin 
levels were found in patients with complicated 
compared to those with non complicated diabetes 
(p<0.0001) table (4). 
 
Table 4. Mean values of P-selectin and MDA in complicated versus non-complicated course diabetics 
 
 Non-complicated diabeticsn =24 
Complicated  diabetics  
N =14 Test of significance  p value 
P-selectin (ng/dl) 
Mean ±SD 







t= 4.98 <0.0001 
MDA (nmoles/ml) 
Mean ±SD 














































































Figure 2. Plots of mean and 95% confidence intervals of MDA (a) and P-selectin (b) showing no overlap 
between the three studied groups with the ability of having sharp cut off points (no false positive or false 
negative). 
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Serum P-selectin levels were related to 
severity of MVC in the studied diabetics as they 
were significantly higher in diabetics with more 
than one (mean of 149.50 ±35.97 ng/dl) compared 
to patients with one MVC (mean of 86.15 ±13.71 
ng/dl, p=0.02), although no significant difference 
was found between them regarding their serum 
MDA (p>0.05) (Fig. 3a, b). 
 The association between OS (MDA level) and 
level of adhesion molecule (P-selectin) was 
examined and a significant positive correlation 
was found between P-selectin and MDA levels in 
the studied diabetics (r = 0.91, p < 0.0001) 
(Fig.4). 
 A significant positive correlation was found 
between MDA and P-selectin levels with disease 
duration, mean random blood glucose, HbAlc, 
diastolic blood pressure, cholesterol, triglycerides 
and LDL levels in the studied diabetic patients. A 
significant negative correlation was found 
between both MDA and P-selectin with HDL 
levels in the studied diabetics (table 5).  
A multiple regression analysis was done to 
identify the parameter that most significantly 
affects both MDA and P-selectin levels. Among 
all studied variables, HbA1c was the most 
significant variable positively associated with 
both MDA and P-selectin levels (p<0.0001) in the 





















































Figure 3. Mean P-selectin levels (a) and MDA levels (b) in patients with single microvascular complication 
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Table 5. Correlation between MDA and P-selectin levels with variable parameters in the studied diabetics. 
 
 MDA P-selectin 
 R p R p 
 Age (year) 0.11 0.57 0.14 0.45 
 Disease duration (year) 0.75 <0.0001 0.85 <0.0001 
 BMI (kg/m²) -0.38 0.04 -0.28 0.12 
 Systolic blood pressure (mmHg) 0.23 0.21 0.28 0.13 
 Diastolic blood pressure (mmHg) 0.40 0.03 0.50 0.005 
 MRBS (mg/dl) 0.63 <0.0001 0.57 0.001 
 HbAlc (%) 0.86 <0.0001 0.80 <0.0001 
 Mean insulin dose (U/kg/d) 0.01 0.95 0.09 0.63 
 Total cholesterol (mg/dl) 0.38 0.04 0.41 0.02 
 Triglyceride (mg/dl) 0.49 0.006 0.63 <0.0001 
 Low density lipoprotein (mg/dl) 0.39 0.03 0.37 0.05 
 High density lipoprotein (mg/dl) -0.39 0.03 -0.39 0.03 
MRBS= mean random blood sugar       BMI=body mass index 
 
Table 6. Multiple regression analysis for the relation of MDA and P-selectin levels to various studied 
parameters 
 







Age -0.16 0.36 -0.07 0.52 
Disease duration 0.24 0.06 0.37 <0.0001 
BMI (kg/m²) -0.07 0.60 0.02 0.83 
HbA1c% 0.61 <0.0001 0.54 <0.0001 
Systolic blood pressure 0.14 0.40 0.08 0.49 
Diastolic blood pressure -0.01 0.95 -0.04 0.73 
Total cholesterol 0.03 0.82 0.00 0.96 
Triglycerides 0.15 0.37 0.42 0.001 
HDL -0.05 0.63 -0.07 0.39 
LDL 0.04 0.78 -0.17 0.13 
HDL: High density lipoprotein, LDL: Low density lipoprotein, BMI: Body mass index, 
MDA: Malondialdehyde and HbA1c: glycated hemoglobin. 
 
  Receiver Operating Characteristic curve 
was done to determine the cut off levels of MDA 
and P-selectin for prediction of microvascular 
affection in diabetics. A cut off value for serum 
MDA  equal to 8.035 nmol/ ml with a sensitivity 
of 96.67% and specificity of 93.33% and for 
serum P-selectin equal to 45.15 ng/dl with a 
sensitivity of 90% and specificity of 100% were 
identified. Elevated levels above these cut off 
values are potentially early markers of 
susceptibility to diabetic microvascular 
complications; table 7 and figure 5. 
 
Table 7. Sensitivity, specificity, PPV, NPV and cut-off values of MDA and P-selectin. 
 
 Sensitivity% Specificity% PPV% NPV% Cut offvalue AUC SE p value
MDA 
(nmoles/ml) 96.67 93.33 93.55 96.55 8.035 
0.99  
(95% CI 0.97 to 1.00) 0.001 <0.001
P-selectin  
(ng/dl) 90 100 100 90.91 45.15 
0.95  
(95%CI 0.89 to 1.00) 0.03 <0.001
PPV: Positive predictive value; NPV: Negative predictive value; AUC: Area under the curve; SE: Standard 
error and MDA: malondialdehyde. 
 
 












Figure 4. Scatter diagram showing a significant 
positive correlation between P-selectin and MDA 



























Source of the curve  
––– MDA (nmoles/ml) 
….. P-selectin ng/dl 
 
Figure 5. Receiver Operating Characteristic (ROC) 




Diabetic patients with disease duration of 5 or more 
years had less glycemic control as evident by an 
increase in mean RBS and mean insulin dose with 
significantly higher HbA1c compared to patients 
with disease duration less than 5 years. 
Furthermore, they experienced more frequent 
episodes of DKA reflecting their less efficient 
control of their diabetic state. 
 Lachin et al.12 reported that each 1% reduction 
in HbA1c levels corresponded to 40% reduced risk 
of developing microvascular disease and it was 
highly related to disease duration. 
This same group of diabetics with higher 
HbA1c had higher percentage of peripheral 
neuropathy and nephropathy compared to patients 
with less than 5 years disease duration. Retinopathy 
was seen in 2/16 patients with long standing 
diabetes and not present in group1. 
Studies documented that the increased risk of 
developing MVCs in type 1 diabetes was increased 
with progression of diabetes duration (13,14). 
Recently Caroli et al.15 reported that, diabetes 
duration is an established risk factor for retinopathy 
and nephropathy. Svensson and colleagues16 
reported that the prevalence of retinopathy 
increased with increasing disease duration, since 
one third of diabetics with duration between 10 and 
12 years developed retinopathy. 
Vincent and coworkers17 demonstrated that the 
most common MVC in diabetes is peripheral 
neuropathy and its incidence increases with 
increased diabetes duration and is accelerated by 
poor glycemic control. They returned that to the 
increased effect of OS with increased disease 
duration, which is associated with the development 
of apoptosis in neurons and supporting glial cells 
and so could be the unifying mechanism that leads 
to nervous system damage in diabetes. 
Hypoglycemia was more frequently 
encountered in patients with shorter disease 
duration. This could be explained by the fact that 
patients attempting to have a good glycemic control 
(as evident by lower HbA1c in group1) are likely to 
have a higher frequency of hypoglycemia and lower 
frequency of DKA attacks18. Golubnitschaja et al.19 
documented an inverse correlation between the 
frequency of hypoglycemic attacks and HbA1c 
level.  
In the present study patients with long standing 
diabetes had higher levels of TC, TG and LDL with 
lower levels of HDL compared to group I diabetics 
and controls. This is contrary to what was reported 
by Erciyas et al.20  who demonstrated that there was 
no significant difference in lipid profile between 
diabetics with long and those with short disease 
duration. On the other hand Jarvisalo et al.21 
reported that the protection afforded by HDL in the 
healthy controls was lost in the diabetic patients.  
Hyperglycemia is the primary mediator of 
atherosclerosis in type1 DM and previous studies 
have shown that intensive insulin treatment had a 
significant effect on serum lipid levels22. Many 
studies have demonstrated serum lipid 
abnormalities in children with T1DM as well as an 
association between elevated HbA1c and 
dyslipidemia23,24. The importance of this association 
emerges from that pediatric dyslipidemia is 
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associated with atherosclerosis and requires 
preventive measures25. As part of these preventive 
measures, there is indirect evidence for the 
importance of glycemic control in improving lipid 
profile in children with T1DM26. Moreover glucose 
is known to increase both cholesterol synthesis and 
OS27, and in the present study diabetics with longer 
diabetes duration had elevated blood glucose with 
elevated HbA1c values. 
In the present study serum MDA was highest in 
diabetics with longer disease duration compared to 
other groups. Varvarovska et al.28 studied the 
aspects of OS in type 1 diabetics and their first 
degree relatives. They confirmed increased OS in 
diabetics and their siblings. A one-year follow-up 
with supplementation of those patients with 
vitamins E and C led to improvement of diabetes 
control and reduced markers of OS compared with 
non-supplemented diabetics.  
Karataş et al.29 reported higher MDA level in 
diabetics with longer disease duration compared to 
newly diagnosed patients. As the disease progresses 
the free radicals production are increased and the 
capacity of antioxidant systems are reduced. Free 
radicals are produced as a result of glycosylation of 
several proteins including hemoglobin by non-
enzymatic mechanisms. Subsequently, these free 
radicals change lipid/protein ratio of membranes by 
affecting poly-unsaturated fatty acids and lipid 
peroxidation causing functional irregularities of 
several cellular organelles30. Lipid peroxides are 
disintegrated quickly forming reactive carbon 
compounds. Among these, MDA is an important 
reactive carbon compound used commonly as an 
indicator of lipid peroxidation31. 
In this study there was a significant increase in 
P-selectin level in diabetics (even with disease 
duration <5 years), with the highest level in those 
with longer disease duration. This means that P-
selectin is increased in diabetics even before the 
occurrence of MVC and this increase was parallel 
to the increase in disease duration. Karayanni et 
al.32 demonstrated increased level of P-selectin as 
early as the first year of diabetes and this was in 
accordance with our results. On the other hand 
Glowinska et al.33 found no change in the level of 
P-selectin in patients with atherosclerotic risk 
factors (obesity, diabetes and hypertension) 
compared to healthy children. 
Pirot et al.34 studied abnormal markers of 
endothelial cell activation and OS in type 1 
diabetics with no clinical vascular disease. They 
demonstrated increased levels of these abnormal 
markers confirming the hypothesis that vascular 
disease starts early in the course of childhood 
diabetes. Recently, Suys et al.30 presented a good 
evidence of early endothelial dysfunction in 
diabetic children. 
  Toivonen et al.35 reported that soluble 
adhesion molecule disturbances started about 4 
years before the clinical manifestations of diabetes, 
which were more obvious about 1.5 years before 
diagnosis. They proposed that adhesion molecules 
were associated with the initiation of destructive 
process of insulinitis with contribution in 
development of diabetes.   
In the present study there was a positive 
correlation between MDA and P-selectin which 
means a strong relation between the degree of OS 
and the damage of the vascular endothelium leading 
to endothelial dysfunction and microangiopathy. 
Suys et al.30 reported a parallelism between OS and 
abnormal markers of endothelial cell dysfunction in 
young patients with T1DM. Karayanni et al.32 
studied 45 type 1 diabetics and they found that P-
selectin elevation was related to the imbalance in 
the oxidant/antioxidant status that accompanied 
diabetes suggesting the association between 
endothelial/platelet activation with OS even in the 
first years of the disease being more pronounced as 
the disease progresses.  
 Soriano et al.36 reported that expression of P-
selectin was among the adverse biological effects 
displayed by the endothelial cells upon exposure to 
ROS. They found that the vascular endothelium 
was the primary target of OS. At higher 
concentrations, ROS react rapidly with endothelial 
nitric oxide (NO) radicals, forming peroxynitrate 
anion and thus decreasing NO bioavailability, 
leading to protein nitration with subsequent 
vascular cell injury37.  
Booth et al.38 reported that ROS may activate 
phospholipases which in turn generate a multitude 
of cellular messengers and cofactors that are critical 
in the regulation of actin binding proteins and 
adhesion molecules expressed on the endothelial 
cell membrane. 
In the present study MDA level was positively 
correlated with disease duration. Changes in 
oxidant and antioxidant systems are related to 
duration of the disease and become more prominent 
as complications develop depending upon the level 
of glycemic control39-41.  
  In a study done by Erciyas et al.20 type 1 
diabetics were evaluated in two groups in view of 
their mean HbA1c values, as metabolically well 
controlled (HbA1c ≤8%) and poorly controlled 
(HbA1c >8%) patients. They concluded increased 
level of MDA and dyslipidemia in poorly controlled 
patients with a positive correlation between MDA 
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level and the levels of TC, LDL, apolipoprotein B. 
These findings go with our study which found a 
positive correlation between glycemic control (RBS 
and HbA1c) and MDA. 
 Suys et al.30 found a negative relationship 
between endogenous scavenger antioxidants and 
levels of HbA1c as well as positive one between 
levels of HbA1c with peroxidation product (MDA) 
in type 1 diabetics. This points out to the 
importance of glycemic control in 
antioxidant/oxidant balance in young diabetics. 
Davi et al.3 reported that enhanced lipid 
peroxidation in recently diagnosed diabetics was 
improved later on parallel to the improvement in 
glycemic control this could be explained by that 
some antioxidants are probably lost due to renal 
hyperfiltration in early phase of T1DM. In addition, 
hyperglycemia leads to redox imbalance and 
glycation of enzymes and can thus cause 
impairment in the recycling of some antioxidants 
molecules such as ascorbate42. Also, it leads to 
enhanced metabolism of glucose through the polyol 
(sorbitol) pathway, which results in increased 
intracellular osmolarity, depleted glutathione 
reserves and enhanced production of free radicals43. 
A positive correlation was evident between OS 
as presented by MDA levels and diastolic blood 
pressure. A possible explanation is that free radicals 
generated from OS had an important role in 
regulation of smooth muscle tone44. Furthermore it 
reacts with NO generating cytotoxic NO which 
alters function of biomolecules by protein nitration; 
potassium channels which regulate the 
vasorelaxation response are inhibited by this 
nitration process45. 
Also the present study revealed a significant 
positive correlation between dyslipidemia and 
MDA levels. Poor metabolic control is associated 
with increase in both OS (evident by high MDA 
levels) and dyslipidemia25. Previous studies 
correlated dyslipidemia in type1 diabetics to poor 
metabolic control whereas optimal glycemic control 
adjusted both dyslipidemia and decrease the level of 
OS46. 
In the present study serum levels of P-selectin 
showed a significant positive correlation with 
disease duration. This was in agreement with 
Karayanni et al.32 who reported elevated level of P-
selectin in diabetics especially those with long 
disease duration. 
Moreover the present study found significant 
positive correlation between parameters of 
metabolic control (RBS and HbA1c) and P-selectin 
level. Brawnlee1 reported that hyperglycemia could 
lead to endothelial damage through multiple 
mechanisms; enhanced polyol pathway, increased 
advanced glycation end products (AGEs), these in 
turn increase production of ROS, with subsequent 
increased expression of endothelial adhesion 
molecules especially P-selectin. Moreover 
hyperglycemia causes a rapid inflammatory 
response in the microcirculation. This response is 
triggered via up regulation of P- selectin on the 
endothelial cell surface probably due to reduced 
endothelial derived NO. This phenomenon might 
represent an important and early mechanism of the 
diabetic microangiopathy31. 
Jarvisalo et al.21 had demonstrated that TG level 
has a positive while HDL level has a negative 
relationship with endothelial dysfunction and 
increased arterial intimae media thickness in 
children with T1DM. 
In the present study HbA1c had the strongest 
effect on serum MDA and P-selectin. Varvaroska et 
al.28 demonstrated a strong relation between OS and 
glycemic control. They achieved improvement of 
metabolic control in response to vitamin E 
supplementation over one year in a group of type 1 
diabetics. Karayainni et al.32 demonstrated that 
elevation of P-selectin in patients with T1DM is 
related to poor glycemic control. 
 Cipollone et al.7 studied the contribution of 
soluble CD40 ligand (sCD40L) and soluble P-
selectin to endothelial cell dysfunction and 
monocytes activation in diabetics (40 type 2 and 30 
type 1 diabetics). They found up regulation of 
sCD40L (a pro-inflammatory agent released from 
activated platelets and associated with diabetic 
vascular complications) as a consequence of 
persistent hyperglycemia resulting in endothelial 
cells activation and monocytes recruitment to the 
arterial wall possibly, contributing to accelerated 
atherosclerosis. Elevated sCD40L in diabetics was 
associated with in vitro adhesion molecules release 
and significantly correlated with HbA1c levels. 
This means that poor glycemic control initiates an 
inflammatory response through, release of cell 
adhesion molecules, especially P-selectin with 
monocytes recruitment to the arterial wall 
contributing to vascular diabetic disease47. 
 In the present study significant increase in 
MDA and P-selectin levels was found in 
complicated compared to non-complicated diabetics 
(p<0.0001). The importance of OS in the etiology 
of diabetes complications is based on the fact that 
the main biochemical pathways (glucose oxidation, 
polyol pathway, protein glycation, and prostanoid 
synthesis) that can increase free radical formation 
are tightly related to hyperglycemia40. Yngen et al.48 
demonstrated significant increase in serum level of  
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soluble P-selectin along with elevated sCD40L and 
C-reactive protein in type 1 diabetics with MVCs 
compared to non complicated and healthy subjects, 
confirming the hypothesis that microangiopathy is 
associated with platelet hyperactivity, endothelial 
dysfunction and low-grade inflammation49. Hu et 
al.50 assessed platelet and leukocyte function and 
cross-talk between these cells in type 1 diabetics 
with and without MVCs. They demonstrated that 
thromboxane A2 analogue induced marked increase 
of platelet P-selectin expression and 
platelet/leukocyte aggregation in diabetics 
compared to healthy controls and this increase was 
more evident in complicated diabetics. This finding 
indicates that platelet and leukocyte dysfunction 
and enhanced leukocyte/platelet cross-talk are 
increased in diabetics with evident relation to 
MVCs. 
In the present study significant increase in 
serum level of P-selectin was found in diabetics 
with more than one MVCs compared to those with 
one MVC (p<0.05). Meanwhile, P-selectin might 
act as a good index of microangiopathy severity. 
Recently elevated levels of adhesion molecules 
especially P-selectin in diabetics with MVCs was 
related to the severity of microcirculatory 
abnormality51,52. Similarly Devaraj et al.5 found that 
increased level of adhesion molecules in 
complicated diabetics with evident relation to the 
severity of microcirculatory abnormality. 
In conclusion; the present study highlights the 
role of OS and adhesion molecules in the 
development of diabetic MVCs and its correlation 
with parameters of metabolic control especially 
HbA1c. It allows better understanding of the early 
steps in the pathophysiology of developing diabetic 
MVCs and so giving a future hope for novel 
therapeutic agents preventing the early crawling 
diabetic vascular disease. An important issue is that 
these findings appear even in patients with short 
non-complicated diabetes course and this provides a 
direct evidence for the beneficial and early effect of 
tight metabolic control and antioxidant therapy in 
prevention of MVCs. 
Recommendations for achieving the appropriate 
metabolic control and management of dyslipidemia 
are the most beneficial in preventing the OS and 
improving endothelial function. Diet of diabetic 
patients should contain the recommended daily 
allowance of antioxidants. Starting antioxidant 
therapy as one of the corner stones of treatment 
early after diagnosis of type 1DM may give a future 




1. Brawnlee B. Biochemistry and molecular cell 
biology of diabetic complications. Nature 2005; 
414: 813-20. 
2. Bertoluci MC, Cé GV, Da Silva AM, Puñales 
MK. Endothelial dysfunction in type 1 diabetes. 
Arq Bras Endocrinol Metabol 2008; 52(2): 416-
26.  
3. Davi G, Chiarelli F, Santilli F. Enhanced 
lipid peroxidation and platelet activation in the 
early phase of type 1 diabetes mellitus, Role of 
interleukin-6 and disease duration. Circulation 
2003; 107: 3199-203. 
4. Ceriello A, Motz E. Is oxidative stress the 
pathogenic mechanism underlying insulin 
resistance, diabetes, and cardiovascular disease? 
The common soil hypothesis revisited. 
Arterioscler Thromb Vasc Biol 2004; 24: 816–
23. 
5. Devaraj S, Cheung AT, Jialal I, Griffen SC, 
Nguyen D, Glaser N, et al . Evidence of 
increased inflammation and microcirculatory 
abnormalities in patients with type 1 diabetes 
and their role in microvascular complications. 
Diabetes 2007; 56 (11): 2790-96.  
6. Madsen-Bouterse SA, Kowluru RA. 
Oxidative stress and diabetic retinopathy: 
Pathophysiological mechanisms and treatment 
perspectives. Rev Endocr Metab Disord 2008; 
[Epub ahead of print]. 
7. Cipollone F, Chiarelli F, Davì G, Ferri C, 
Desideri G, Fazia M, et al. Enhanced soluble 
CD40 ligand contributes to endothelial cell 
dysfunction in vitro and monocyte activation in 
patients with diabetes mellitus: effect of 
improved metabolic control. Diabetologia 2005; 
48(6): 1216-24. 
8. Jiménez D, Roda-Navarro P, Springer TA, 
Casasnovas JM. Contribution of N-linked 
glycans to the conformation and function of 
intercellular adhesion molecules (ICAMs). J Biol 
Chem 2005; 280(7): 5854-61. 
9. Kelly LD, Steeber DA, Tedder TF, Bochner 
BS. P-and L- selectin mediate distinct but 
overlapping functions in endotoxin-induced 
leukocyte-endothelial interactions in the rat 
microcirculation. J Immunol 2003; 159:1977-86. 
10. Manka D, Forlow SB, Sanders JM. Critical 
role of platelet P-selectin in the response to 
arterial injury in polylipoprotein-E-deficient 
mice. Arterioscler Thromb Vasc Biol 2004; 24: 
1124-29.  
El-Samahy et al. 
 76
11. Sempe M, Pedrong G and Roy-Ternot NP. 
Auxologie le methodes et sequences. Paris: 
Theraplix 1979.  
12. Lachin JM, Genuth S, Nathan DM, Zinman B, 
Rutledge BN; DCCT/EDIC Research Group. Effect 
of glycemic exposure on the risk of 
microvascular complications in the diabetes 
control and complications trial--revisited. 
Diabetes 2008; 57(4): 995-1001. 
13. Drummond KN, Kramer MS, Suissa S, Levy-
Marchal C, Dell Aniello S, Sinaiko A , et 
al. International Diabetic Nephropathy Study 
Group. Effects of duration and age at onset of 
type 1 diabetes on preclinical manifestations of 
nephropathy.  Diabetes 2003; 52: 1818-24. 
14. Kulenovic I, Rasic S, Karcic S. Development 
of microvascular complications in type 1 
diabetic patients 10 years follow-up. Bosn J 
Basic Med Sci 2006; 6(2): 47-50. 
15. Caroli G, Paganelli A, Fattori G, Daghio 
MM, Guidetti P, Borsari S, et al. Prevention 
of diabetes mellitus complications and 
improvement of early diagnosis at a population 
level, through the implementation of disease 
management in Modena Local Health Unit. 
Recenti Prog Med 2008; 99(4): 200-3. 
16. Svensson M, Eriksson JW, Dahlquist G. 
Early Glycemic Control, Age at Onset, and 
Development of Microvascular Complications in 
Childhood-Onset Type 1 Diabetes.  Diabetes 
Care 2004; 27: 955-62.  
17. Vincent AML, James W, Russell PL, Feldman 
EL. Oxidative Stress and Diabetic Neuropathy.  
Endocrine Reviews 2004; 25(4): 612–28. 
18. Frier BM. How hypoglycaemia can affect the 
life of a person with diabetes. Diabetes Metab 
Res Rev 2008; 24(2): 87-92. 
19. Golubnitschaja O. Diabetes care: risk factors, 
prediction, prevention and individualized 
treatment. Infect Disord Drug Targets 2008; 
8(2):68-9. 
20. Erciyas Fa, Taneli F, Arslan B, Uslu Y. 
Glycemic control, oxidative stress, and lipid 
profile in children with type 1 diabetes mellitus. 
Archives of Medical Research 2004;  35 (2): 
134-40. 
21. Jarvisalo MJ, Raitakari M, Toikka JO, 
Putto-Laurila A, Rontu R, Laine S, et al. 
Endothelial dysfunction and increased arterial 
intima-media thickness in children with type 1 
diabetes. Circulation 2004; 109:1750–55. 
22. The Diabetes Control and Complications Trial 
(DCCT) Research Group. Effect of intensive 
diabetes management on macrovascular events 
and risk factors in the diabetes control and 
complications trial. Am J Cardiol 1995; 75: 894-
903. 
23. Rodriguez BL, Fujimoto WY, Mayer-Davis 
EJ, Imperatore G, Williams DE, Bell RA, et 
al. Prevalence of cardiovascular disease risk 
factors in U.S. children and adolescents with 
diabetes: the SEARCH for diabetes in youth 
study. Diabetes Care 2006; 29: 1891-6. 
24. Gunczler P, Lanes R, Soros A, Verdu L, 
Ramon Y, Guevara B, et al. Coronary artery 
calcification, serum lipids, lipoproteins, and 
peripheral inflammatory markers in adolescents 
and young adults with type 1 diabetes. J Pediatr 
2006; 149: 320-3. 
25. Shamir R, Kassis H, Kaplan M, Naveh T, 
Shehadeh N. Glycemic control in adolescents 
with type 1 diabetes mellitus improves lipid 
serum levels and oxidative stress. Pediatr 
Diabetes 2008; 9: 104-9. 
26. American Diabetes Association. Management of 
dyslipidemia in children and adolescents with 
diabetes. Diabetes Care 2003; 26: 21194-7. 
27. Dandona P, Mohanty P, Chaudhuri A, Garg 
R, Aljada A. Insulin infusion in acute illness. J 
Clin Invest 2005; 115: 2069-72. 
28. Varvarovská J, Racek J, Štetina R, Sýkora 
J, Pomahačová R, Rušavý Z, et al. Aspects of 
oxidative stress in children with Type 1 diabetes 
mellitus. Biomedecine. Pharmacotherapy 2004;  
58 (10): 539-45. 
29. Karataş F, Halifeoğlu I, Karatepe M, Konar 
V, Canatan H, Çolak R. Evaluation of changes 
in levels of serum selenium, MDA and 
antioxidant vitamins (A, E, C) in diabetic 
patients. Araştirma 2006; 20 (6): 391–5. 
30. Suys B, Lieve Op, Raoul R, Kransfeld S, 
Heuten H, Goovaerts I, et al. Impact of 
oxidative stress on the endothelial dysfunction of 
children and adolescents with type 1 diabetes 
mellitus: protection by superoxide dismutase?  
Pediatr Res 2007; 62: 456– 61. 
Oxidative stress and p-selectin in type 1 diabetics 
 77
31. Dave GS, Kalia K. Hyperglycemia induced 
oxidative stress in type-1 and type-2 diabetic 
patients with and without nephropathy. Cell Mol 
Biol (Noisy-le-grand) 2007; 53(5): 68-78.  
32. Karayanni MC, Gourgiotis D, Bossios A, 
Kamper EF. Oxidative stress and adhesion 
molecules in children with type 1 diabetes 
mellitus: a possible link. Pediatric Diabetes 
2006; 7(1):51-9. 
33. Głowinska B, Urban M, Peczynska J, Florys 
B. Selectins in the pathogenesis and diagnosis of 
early atherosclerotic changes in children and 
adolescents with risk factors (obesity, 
hypertension and diabetes). Przegl Lek 2004; 
61(9): 935-9. 
34. Pirot P, Cardozo AK, Eizirik DL. Mediators 
and mechanisms of pancreatic beta-cell death in 
type 1 diabetes. Arq Bras Endocrinol Metabol 
2008; 52(2):156-65. 
35. Toivonen AM, Kulmala P, Savola K, 
Akerblom HK, Knip M. Soluble adhesion 
molecules in pre-clinical type 1 diabetes: a 
prospective study. Diabetologia 2003; 46: 492-5.  
36. Soriano FG, Virag L, Szabo C. Diabetic 
endothelial dysfunction: role of reactive oxygen 
and nitrogen species production and poly (ADP-
ribose) polymerase activation. J Mol Med 2001; 
79:437–48. 
37. Pei XH, Lin ZX, Geng JG. [Expression and 
identification of recombinant P-selectin and P-
selectin glycoprotein ligand-1.] Sheng Li Xue 
Bao 2008; 60(4):520-4(Article in Chinese). 
38. Booth G, Stalker TJ, Lefer AM, Scalia R. 
Mechanisms of Amelioration of Glucose-
Induced Endothelial Dysfunction Following 
Inhibition of Protein Kinase C. In vivo. Diabetes 
2002; 51: 1556–64. 
39. Danne T, Karin L, Olga K. New developments 
in the treatment of type 1 diabetes in children. 
Archives of Disease in Childhood 2007; 
92:1015-9. 
40. Gasser A, Forbes JM. Advanced glycation: 
implications in tissue damage and disease. 
Protein Pept Lett 2008; 15(4): 385-91. 
41. Jones PM, Courtney ML, Burns CJ, Persaud 
SJ. Cell-based treatments for diabetes. Drug 
Discov Today 2008; [Epub ahead of print]. 
42. Fridlyand LE, Philipson LH. Oxidative 
reactive species in cell injury: Mechanisms in 
diabetes mellitus and therapeutic approaches. 
Ann N Y Acad Sci 2005; 1066: 136-51. 
43. Gupta A, Tripathi AK, Tripathi RL, Madhu 
SV, Banerjee BD. Advanced glycosylated end 
products-mediated activation of 
polymorphonuclear neutrophils in diabetes 
mellitus and associated oxidative stress. Indian J 
Biochem Biophys 2007; 44(5): 373-8. 
44. Droge W.  Free radicals in the physiological 
control of cell function. Physiol Rev 2002; 
82(1): 47-95. 
45. Liu Y, Guttermann DD. The coronary 
circulation in diabetes: influence of reactive 
oxygen species on K+ channel-mediated 
vasodilation. Vascul Pharmacol 2002; 38: 43-9. 
46. Maahs DM, Wadwa RP, McFann K, Nadeau K, 
Williams MR, Eckel RH, et al. Longitudinal 
lipid screening and use of lipid lowering 
medications in pediatric type 1 diabetes. J 
Pediatr 2007; 150: 146-50. 
47. Zietkowski Z, Skiepko R, Tomasiak MM, 
Bodzenta-Lukaszyk A. Soluble CD40 ligand 
and soluble P-selectin in allergic asthma patients 
during exercise-induced bronchoconstriction. J 
Investig Allergol Clin Immunol 2008; 18(4):272-
8. 
48. Yngen M, Östenson CG, Hu H, Li 
N, Hjemdahl P, Wallén N H. Enhanced P-
selectin expression and increased soluble CD40 
Ligand in patients with Type 1 diabetes mellitus 
and microangiopathy: evidence for platelet 
hyperactivity and chronic inflammation. 
Diabetologia 2004; 47:537-40. 
49. Aronson D. Hyperglycemia and the 
pathobiology of diabetic complications.   Adv 
Cardiol 2008; 45: 1-16. 
50. Hu H, Li N, Yngen M, Ostenson CG, Wallen 
NH, Hjemdahl P. Enhanced leukocyte-platelet 
cross talk in type 1 diabetes mellitus: 
relationship to microangiopathy. J Thromb 
Haemost 2004; 2(1): 58-64. 
51. Sawa Y, Tsuruga E, Iwasawa K, Ishikawa H, 
Yoshida S. Leukocyte adhesion molecule and 
chemokine production through lipoteichoic acid 
recognition by toll-like receptor 2 in cultured 
human lymphatic endothelium. Cell Tissue Res 
2008; 333(2): 237-52. 
52. Orasanu G, Plutzky J. The pathologic 
continuum of diabetic vascular disease. J Am 
Coll Cardiol  2009; 53 (5 suppl): s35-s42. 
